What are the key laboratory ratios used to assess thyroid and liver function, and what are their normal reference values?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Key Laboratory Ratios and Reference Values for Thyroid and Liver Assessment

For thyroid function, TSH (0.66-5.84 mIU/L) and free T4 (8.62-14.71 pmol/L) are the essential tests, while for liver assessment, ALT, ALP, GGT, bilirubin, and albumin form the core panel, with no single "ratio" being standard but rather patterns of elevation guiding diagnosis. 1, 2

Thyroid Function Testing

Primary Tests and Reference Values

TSH is the single most important screening test for thyroid dysfunction 3, 4:

  • Male reference range: 0.66-4.95 mIU/L
  • Female reference range: 0.72-5.84 mIU/L 2

Free T4 (FT4) reference values 2:

  • Male: 8.97-14.71 pmol/L
  • Female: 8.62-14.35 pmol/L

Free T3 (FT3) reference values 2:

  • Male: 3.75-5.81 pmol/L
  • Female: 3.59-5.56 pmol/L

Diagnostic Thresholds for Thyroid Disease

Subclinical hypothyroidism: TSH 4.5-10 mIU/L with normal FT4 3

Overt hypothyroidism: TSH >10 mIU/L with low FT4, or high TSH with low-normal FT4 plus symptoms 3

Subclinical hyperthyroidism: TSH <0.4 mIU/L (or more specifically <0.1 mIU/L) with normal FT4/T3 3

Overt hyperthyroidism: TSH <0.1 mIU/L with elevated FT4, T3, or FT3 3

Important Thyroid Ratios (Emerging Clinical Utility)

The T3/T4 ratio is gaining recognition as a marker of thyroid hormone conversion and tissue-level thyroid status, though not yet standard practice. This ratio may provide additional information about metabolic consequences even in biochemically euthyroid patients 5.

Critical Pitfall: Chronic Liver Disease

In patients with chronic liver disease, TSH alone is the most reliable test 4. Total T4, T3, and binding protein measurements are frequently abnormal despite clinical euthyroidism due to:

  • Altered thyroxine binding globulin levels
  • Reduced T3 levels correlating with disease severity
  • Elevated FT4 with low-normal FT3 maintaining euthyroid state 6

The simplified approach: Use TSH immunoradiometric assay (IRMA) as a single test in chronic liver disease patients—it removes uncertainties from binding protein abnormalities 4.

Liver Function Testing

Standard Liver Blood Test Panel

The essential initial panel includes 1:

  • Bilirubin
  • Albumin
  • ALT (alanine aminotransferase)
  • ALP (alkaline phosphatase)
  • GGT (gamma-glutamyl transferase)
  • Full blood count (if not done within 12 months)

Key Patterns Rather Than Ratios

Unlike thyroid testing, liver assessment relies on patterns of enzyme elevation rather than specific ratios:

Hepatocellular pattern: Predominantly elevated ALT/AST (>5x upper limit suggests acute hepatocellular injury)

Cholestatic pattern: Predominantly elevated ALP/GGT

Mixed pattern: Both hepatocellular and cholestatic markers elevated

Important Liver-Related Indices

AST/ALT ratio: Though not mentioned in the guideline, this is clinically useful:

  • Ratio >2 suggests alcoholic liver disease
  • Ratio <1 typical in viral hepatitis or NAFLD

Platelet count: Low platelets indicate advanced fibrosis/cirrhosis due to splenic sequestration from portal hypertension 1

Non-Invasive Fibrosis Markers

FIB-4 Index (Fibrosis-4): Uses age, AST, ALT, and platelet count to assess liver fibrosis 5

FLI (Fatty Liver Index): Assesses hepatic steatosis 5

Extended Liver Aetiology Panel

When initial tests are abnormal, proceed with 1:

  • Viral hepatitis: HBsAg, HCV antibody (with PCR if positive)
  • Iron overload: Ferritin AND transferrin saturation
  • Autoimmune: AMA, ASMA, ANA, immunoglobulins
  • Metabolic: Alpha-1-antitrypsin, thyroid function tests, caeruloplasmin (age 3-40 years)

Thyroid-Liver Interaction

In NAFLD patients, elevated TSH (even within normal range) and elevated neutrophil-to-lymphocyte ratio (NLR) correlate with disease severity 7. High-normal FT3 and low-normal TSH predict incident NAFLD in euthyroid subjects 8.

Clinical Algorithm

  1. Screen with TSH for thyroid dysfunction (add FT4 if TSH abnormal)
  2. Screen with ALT, ALP, GGT, bilirubin, albumin for liver disease
  3. If chronic liver disease present: Use TSH-IRMA alone for thyroid assessment
  4. If both abnormal: Consider thyroid-liver axis interaction—thyroid dysfunction can worsen liver disease and vice versa

Age considerations: FT4, FT3, and total T3 decline with age; adjust interpretation accordingly 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.